Advertisement
Advertisement
Cheshire East set to invest in Alderley Park bio-science hub

Cheshire East set to invest in Alderley Park bio-science hub

Cheshire East Council is set to invest in the Alderley Park bio-science hub which the new owners are suggesting could create up to 5,000 jobs. Following…
AstraZeneca announces sale of Alderley Park

AstraZeneca announces sale of Alderley Park

AstraZeneca today announced the sale of its Alderley Park site to Manchester Science Parks (MSP), a Greater Manchester based public-private partnership…
100 staff now employed at Alderley Park BioHub

100 staff now employed at Alderley Park BioHub

Last week we reported that the third wave of companies has arrived at the BioHub at AstraZeneca's Alderley Park site. In total the BioHub now houses approximately…
Third wave of new tenants arrive at Alderley Park BioHub

Third wave of new tenants arrive at Alderley Park BioHub

AstraZeneca today announced the third wave of arrivals at the BioHub at its Alderley Park site. Staff at Molplex Ltd, Absynth Biologics and Agenda1 Analytical…
Parts of Alderley Park could be released for housing

Parts of Alderley Park could be released for housing

Following the announcement by AstraZeneca of their plans to reduce the scale of their operation at Alderley Park to around 700 jobs by 2016, Cheshire…
Alderley Park recognised for its outstanding scientific achievements

Alderley Park recognised for its outstanding scientific achievements

Alderley Park is one of four sites of special scientific interest linked to discoveries and contributions in pharmacology to have won recognition in a…
First tenants for Alderley Park announced

First tenants for Alderley Park announced

Cheshire East Council's aim to build a Bio Science Park and incubator of global significance at AstraZeneca's Alderley Park base has been given a boost…
Unite urges AstraZeneca to reconsider plans for Alderley Park

Unite urges AstraZeneca to reconsider plans for Alderley Park

Unite, Britain's biggest union, are meeting senior bosses at AstraZeneca today (Monday 29th April) to urge the pharmaceutical giant to reconsider its…
Advertisement
Advertisement